Renal Denervation Market

Maternal Health Market by Applications (Clinics, Home Care, Hospitals, and Others), Types of Pregnancy (Ectopic, Intrauterine, and Tubal), Types (Hormones, Nutritive, Anti-infective, Analgesics, and Others), Delivery Types (Cesarian Section, Vaginal Delivery, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2022 – 2030

  • Report ID: HC-4153
  • Author: Growth Market Reports
  • Rating: 4.6
  • Total Reviews: 2
  • No. Of Pages: 168
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global maternal health market size was valued at around USD 27,839 million in 2021 and is anticipated to expand at a CAGR of 8.55% during the forecast period, 2022–2030. The growth of the market is attributed to the increasing awareness regarding maternal health among people and its advantages.

Maternal Health Market_Summary

Maternal health is referred as women's health during pregnancy, childbirth, and the postpartum period. Maternal health encompasses healthcare components of family planning, prenatal, preconception, and postnatal care to promote a positive and gratifying experience. It also reduces maternal morbidity and death. Excessive blood loss, high blood pressure, unsafe abortion, infection, and obstructed labor are prevalent direct causes of injury and death among women, while indirect factors include anemia, malaria, and heart diseases. A majority of maternal deaths can be avoided if qualified health practitioners worked in a supportive atmosphere.

The COVID-19 pandemic has caused widespread disruption in healthcare workflows around the world. Various industries, including several sub-domains of the healthcare industry, have been forced to temporarily stop their operations due to the spread of Coronavirus disease. Furthermore, several healthcare services, notably the mother and child healthcare, have suffered unfavorable consequences. The pandemic produced substantial disruptions in the global pharmaceutical and medical supply chain. Although COVID-19 death rates in children and women of reproductive age appear to be low, these groups are expected to disproportionately affect due to inefficient routine health services, particularly in low- and middle-income country such as India.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing adoption of mother healthcare services is expected to drive the market.
  • Rising need for parents to seek opinions from super-specialists is projected to propel the market during the forecast period.
  • Supply chain disruption of medicine and drugs in rural area is anticipated to hinder the market.
  • Limited availability of treatment options is expected to hamper the market in the coming years.
  • Rising disposable income and growing birth rates are projected to create lucrative opportunities in the market.

Scope of the Report

The report on the global maternal health market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Maternal Health Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2021

Historic Data

2019–2020

Forecast Period

2022–2030

Segmentation

Applications (Clinics, Home Care, Hospitals, and Others), Types of Pregnancy (Ectopic, Intrauterine, and Tubal), Types (Hormones, Nutritive, Anti-infective, Analgesics, and Others), and Delivery Types (Cesarian Section, Vaginal Delivery, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

MedTech Boston; Merck Sharp & Dohme Corp.; RAND Corporation; SYNAPSE; International Federation; Agile Therapeutics; Johnson & Johnson Services, Inc.; Jiovio Healthcare; and McKinsey & Company

Market Segment Insights

Hospitals segment to expand at a considerable CAGR

On the basis of applications, the maternal health market is segmented into clinics, home care, hospitals, and others. The hospitals segment is projected to expand at a considerable CAGR during the forecast period, due to rising birth rate. The clinics segment is anticipated to account for a major share of the market during the forecast period, owing to rising disposable income.

Maternal Health Market_by Applications

Ectopic segment to hold a significant share of the market

Based on types of pregnancies, the market is divided into ectopic, intrauterine, and tubal. The ectopic segment is expected to hold a significant share of the market in the coming years, due to rising number of pregnancies. The tubal segment accounts for a significant share of the market, owing to the increasing awareness among customers regarding advantages of maternal health.

Hormones segment to expand at a substantial CAGR

On the basis of types, the maternal health market is segregated into hormones, nutritive, anti-infective, analgesics, and others. The hormones segment is anticipated to expand at a substantial CAGR during the forecast period, owing to robust R&D activities. The anti-infective segment is expected to hold a significant share of the market, due to increasing incidences of sexually transmitted diseases.

Vaginal delivery segment to hold considerable market share

Based on delivery types, the market is categorized as Cesarean section, vaginal delivery, and others. The vaginal delivery segment is projected to constitute a considerable share of the market in the coming years, due to the increasing number of emergency referral system. Rising number of lifestyle ailments are causing complications during delivery, thus many healthcare professionals and mothers opt for Cesarean section, which in turn is fueling the growth of the segment.

North America is anticipated to constitute a key market share

In terms of regions, the global maternal health market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to constitute a key share of the market during the forecast period, owing to increasing disposable income. The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period, due to the rising presence of numerous companies in countries such as China and India, growing prevalence of gynecological ailments, and increasing population.

Maternal Health Market_by Regions

Segments

The global maternal health market has been segmented on the basis of

Applications
  • Clinics
  • Home Care
  • Hospitals
  • Others
Types of Pregnancy
  • Ectopic
  • Intrauterine
  • Tubal
Types
  • Hormones
  • Nutritive
  • Anti-infective
  • Analgesics
  • Others
Delivery Types
  • Cesarean Section
  • Vaginal Delivery
  • Others
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players

Competitive Landscape

Key players operating in the global maternal health market are MedTech Boston; Merck Sharp & Dohme Corp.; RAND Corporation; SYNAPSE; International Federation; Agile Therapeutics; Johnson & Johnson Services, Inc.; Jiovio Healthcare; and McKinsey & Company

Product launches and organic growth strategies, such as participation in events, are being prioritized by a number of companies. These companies also adopt acquisitions and collaborations to increase the growth of the market.

Maternal Health Market_Key players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Renal Denervation Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Renal Denervation Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Renal Denervation Market - Supply Chain
  4.5. Global Renal Denervation Market Forecast
     4.5.1. Renal Denervation Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Renal Denervation Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Renal Denervation Market Absolute $ Opportunity
5. Global Renal Denervation Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Renal Denervation Market Size and Volume Forecast by Applications
     5.3.1. Clinics
     5.3.2. Home Care
     5.3.3. Hospitals
     5.3.4. Others
     5.3.5.  
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Renal Denervation Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Renal Denervation Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Renal Denervation Demand Share Forecast, 2019-2026
7. North America Renal Denervation Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Renal Denervation Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Renal Denervation Market Size and Volume Forecast by Applications
     7.4.1. Clinics
     7.4.2. Home Care
     7.4.3. Hospitals
     7.4.4. Others
     7.4.5.  
  7.5. Basis Point Share (BPS) Analysis by Applications
  7.6. Y-o-Y Growth Projections by Applications
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Renal Denervation Demand Share Forecast, 2019-2026
8. Latin America Renal Denervation Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Renal Denervation Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Renal Denervation Market Size and Volume Forecast by Applications
     8.4.1. Clinics
     8.4.2. Home Care
     8.4.3. Hospitals
     8.4.4. Others
     8.4.5.  
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Renal Denervation Demand Share Forecast, 2019-2026
9. Europe Renal Denervation Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Renal Denervation Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Renal Denervation Market Size and Volume Forecast by Applications
     9.4.1. Clinics
     9.4.2. Home Care
     9.4.3. Hospitals
     9.4.4. Others
     9.4.5.  
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Renal Denervation Demand Share Forecast, 2019-2026
10. Asia Pacific Renal Denervation Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Renal Denervation Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Renal Denervation Market Size and Volume Forecast by Applications
     10.4.1. Clinics
     10.4.2. Home Care
     10.4.3. Hospitals
     10.4.4. Others
     10.4.5.  
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Renal Denervation Demand Share Forecast, 2019-2026
11. Middle East & Africa Renal Denervation Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Renal Denervation Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Renal Denervation Market Size and Volume Forecast by Applications
     11.4.1. Clinics
     11.4.2. Home Care
     11.4.3. Hospitals
     11.4.4. Others
     11.4.5.  
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Renal Denervation Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Renal Denervation Market: Market Share Analysis
  12.2. Renal Denervation Distributors and Customers
  12.3. Renal Denervation Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. MedTech Boston
     12.4.2. Merck Sharp & Dohme Corp.
     12.4.3. RAND Corporation
     12.4.4. SYNAPSE
     12.4.5. International Federation
     12.4.6. Agile Therapeutics
     12.4.7. Johnson & Johnson Services, Inc.
     12.4.8. Jiovio Health
The global maternal health market has been segmented on the basis of

Applications
  • Clinics
  • Home Care
  • Hospitals
  • Others
Types of Pregnancy
  • Ectopic
  • Intrauterine
  • Tubal
Types
  • Hormones
  • Nutritive
  • Anti-infective
  • Analgesics
  • Others
Delivery Types
  • Cesarean Section
  • Vaginal Delivery
  • Others
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players

Key players operating in the global maternal health market are MedTech Boston; Merck Sharp & Dohme Corp.; RAND Corporation; SYNAPSE; International Federation; Agile Therapeutics; Johnson & Johnson Services, Inc.; Jiovio Healthcare; and McKinsey & Company

Product launches and organic growth strategies, such as participation in events, are being prioritized by a number of companies. These companies also adopt acquisitions and collaborations to increase the growth of the market.

Maternal Health Market_Key players

Buy Report

FAQ Section

Some frequently asked quetions about this report!

The global maternal health market size was valued at around USD 27,839 million in 2021 during the forecast period, 2022–2030.

Rising need for parents to seek opinion from super-specialists is projected to propel the market during the forecast period.

The global maternal health market is anticipated to expand at a CAGR of 8.55% during the forecast period, 2022–2030.

North America is expected to constitute a key share of the market during the forecast period, owing to increasing disposable income.

Key players competing in the global maternal health market are MedTech Boston; Merck Sharp & Dohme Corp.; RAND Corporation; SYNAPSE; International Federation; Agile Therapeutics; Johnson & Johnson Services, Inc.; Jiovio Healthcare; and McKinsey & Company